Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine for Mild and Severe COVID-19
NCT04367168Phase 2Terminated
- Sponsor
- Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
- Start
- May 2020
- Primary completion
- Apr 2021
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of colchicine in coronavirus disease 2019 (COVID-19), sponsored by Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. Started May 2020; status: terminated.
02
Drugs
colchicine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04367168.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04367168.